Selected research
Industry Research
Gingivitis Medicine Industry Research Report 2026
Market perspective
The global Gingivitis Medicine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Gingivitis Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Gingivitis Medicine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Gingivitis Medicine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Gingivitis Medicine include Lion Corporation, OraPharma Inc, Sunstar Group, GlaxoSmithKline, Hainan Jianke Pharmaceutical, Jiangsu Chenpai Pharmaceutical and South China Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Gingivitis Medicine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Gingivitis Medicine Market by Company
Lion Corporation
OraPharma Inc
Sunstar Group
GlaxoSmithKline
Hainan Jianke Pharmaceutical
Jiangsu Chenpai Pharmaceutical
South China Pharmaceutical
Gingivitis Medicine Segment by Type
Iodine Glycerol
Chlorhexidine
Hydrochloride
Gingivitis Medicine Segment by Application
Ointment
Mouthwash
Toothpaste
Gingivitis Medicine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gingivitis Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gingivitis Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gingivitis Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Gingivitis Medicine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Gingivitis Medicine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Gingivitis Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Iodine Glycerol
- Chlorhexidine
- Hydrochloride
Applications
- Ointment
- Mouthwash
- Toothpaste
Companies covered
- Lion Corporation
- OraPharma Inc
- Sunstar Group
- GlaxoSmithKline
- Hainan Jianke Pharmaceutical
- Jiangsu Chenpai Pharmaceutical
- South China Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Gingivitis Medicine Market Size (2021-2032)
- 2.2.2 Global Gingivitis Medicine Sales (2021-2032)
- 2.2.3 Global Gingivitis Medicine Market Average Price (2021-2032)
- 2.3 Gingivitis Medicine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Iodine Glycerol
- 2.3.3 Chlorhexidine
- 2.3.4 Hydrochloride
- 2.4 Gingivitis Medicine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Ointment
- 2.4.3 Mouthwash
- 2.4.4 Toothpaste
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Gingivitis Medicine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Gingivitis Medicine Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Gingivitis Medicine Revenue of Manufacturers (2021-2026)
- 3.4 Global Gingivitis Medicine Average Price by Manufacturers (2021-2026)
- 3.5 Global Gingivitis Medicine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Gingivitis Medicine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Gingivitis Medicine, Product Type & Application
- 3.8 Global Manufacturers of Gingivitis Medicine, Established Date
- 3.9 Global Gingivitis Medicine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Lion Corporation
- 4.1.1 Lion Corporation Company Information
- 4.1.2 Lion Corporation Business Overview
- 4.1.3 Lion Corporation Gingivitis Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Lion Corporation Gingivitis Medicine Product Portfolio
- 4.1.5 Lion Corporation Recent Developments
- 4.2 OraPharma Inc
- 4.2.1 OraPharma Inc Company Information
- 4.2.2 OraPharma Inc Business Overview
- 4.2.3 OraPharma Inc Gingivitis Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 OraPharma Inc Gingivitis Medicine Product Portfolio
- 4.2.5 OraPharma Inc Recent Developments
- 4.3 Sunstar Group
- 4.3.1 Sunstar Group Company Information
- 4.3.2 Sunstar Group Business Overview
- 4.3.3 Sunstar Group Gingivitis Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sunstar Group Gingivitis Medicine Product Portfolio
- 4.3.5 Sunstar Group Recent Developments
- 4.4 GlaxoSmithKline
- 4.4.1 GlaxoSmithKline Company Information
- 4.4.2 GlaxoSmithKline Business Overview
- 4.4.3 GlaxoSmithKline Gingivitis Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 GlaxoSmithKline Gingivitis Medicine Product Portfolio
- 4.4.5 GlaxoSmithKline Recent Developments
- 4.5 Hainan Jianke Pharmaceutical
- 4.5.1 Hainan Jianke Pharmaceutical Company Information
- 4.5.2 Hainan Jianke Pharmaceutical Business Overview
- 4.5.3 Hainan Jianke Pharmaceutical Gingivitis Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hainan Jianke Pharmaceutical Gingivitis Medicine Product Portfolio
- 4.5.5 Hainan Jianke Pharmaceutical Recent Developments
- 4.6 Jiangsu Chenpai Pharmaceutical
- 4.6.1 Jiangsu Chenpai Pharmaceutical Company Information
- 4.6.2 Jiangsu Chenpai Pharmaceutical Business Overview
- 4.6.3 Jiangsu Chenpai Pharmaceutical Gingivitis Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Jiangsu Chenpai Pharmaceutical Gingivitis Medicine Product Portfolio
- 4.6.5 Jiangsu Chenpai Pharmaceutical Recent Developments
- 4.7 South China Pharmaceutical
- 4.7.1 South China Pharmaceutical Company Information
- 4.7.2 South China Pharmaceutical Business Overview
- 4.7.3 South China Pharmaceutical Gingivitis Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 South China Pharmaceutical Gingivitis Medicine Product Portfolio
- 4.7.5 South China Pharmaceutical Recent Developments
5 Global Gingivitis Medicine Market Scenario by Region
- 5.1 Global Gingivitis Medicine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Gingivitis Medicine Sales by Region: 2021-2032
- 5.2.1 Global Gingivitis Medicine Sales by Region: 2021-2026
- 5.2.2 Global Gingivitis Medicine Sales by Region: 2027-2032
- 5.3 Global Gingivitis Medicine Revenue by Region: 2021-2032
- 5.3.1 Global Gingivitis Medicine Revenue by Region: 2021-2026
- 5.3.2 Global Gingivitis Medicine Revenue by Region: 2027-2032
- 5.4 North America Gingivitis Medicine Market Facts & Figures by Country
- 5.4.1 North America Gingivitis Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Gingivitis Medicine Sales by Country (2021-2032)
- 5.4.3 North America Gingivitis Medicine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Gingivitis Medicine Market Facts & Figures by Country
- 5.5.1 Europe Gingivitis Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Gingivitis Medicine Sales by Country (2021-2032)
- 5.5.3 Europe Gingivitis Medicine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Gingivitis Medicine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Gingivitis Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Gingivitis Medicine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Gingivitis Medicine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Gingivitis Medicine Market Facts & Figures by Country
- 5.7.1 South America Gingivitis Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Gingivitis Medicine Sales by Country (2021-2032)
- 5.7.3 South America Gingivitis Medicine Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Gingivitis Medicine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Gingivitis Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Gingivitis Medicine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Gingivitis Medicine Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Gingivitis Medicine Sales by Type (2021-2032)
- 6.1.1 Global Gingivitis Medicine Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Gingivitis Medicine Sales Market Share by Type (2021-2032)
- 6.2 Global Gingivitis Medicine Revenue by Type (2021-2032)
- 6.2.1 Global Gingivitis Medicine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Gingivitis Medicine Revenue Market Share by Type (2021-2032)
- 6.3 Global Gingivitis Medicine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Gingivitis Medicine Sales by Application (2021-2032)
- 7.1.1 Global Gingivitis Medicine Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Gingivitis Medicine Sales Market Share by Application (2021-2032)
- 7.2 Global Gingivitis Medicine Revenue by Application (2021-2032)
- 7.2.1 Global Gingivitis Medicine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Gingivitis Medicine Revenue Market Share by Application (2021-2032)
- 7.3 Global Gingivitis Medicine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Gingivitis Medicine Value Chain Analysis
- 8.1.1 Gingivitis Medicine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Gingivitis Medicine Production Mode & Process
- 8.2 Gingivitis Medicine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Gingivitis Medicine Distributors
- 8.2.3 Gingivitis Medicine Customers
9 Global Gingivitis Medicine Analyzing Market Dynamics
- 9.1 Gingivitis Medicine Industry Trends
- 9.2 Gingivitis Medicine Industry Drivers
- 9.3 Gingivitis Medicine Industry Opportunities and Challenges
- 9.4 Gingivitis Medicine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst